We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Components of RNA Activation Complex Identified

By Biotechdaily staff writers
Posted on 02 Oct 2002
Working with the microscopic worm C elegans, researchers have identified a protein complex that functions enzymatically to activate specific RNA molecules, which prevents their degradation in the cytoplasm. More...
These findings were reported in the September 19, 2002, issue of Nature.

While studying the embryonic development of C elegans, researchers from the University of Wisconsin (Madison, USA) observed two proteins, GLD-2 and GLD-3, that when combined formed an enzyme that was able to activate specific RNA molecules outside the nucleus. GLD-2 was found to contain an active site where reactions could take place, but this protein did not bind to RNA. GLD-3 behaved in the opposite fashion: it could bind to RNA but had no active site. Binding the two proteins together created an enzyme that could not only attach itself to RNA but could also chemically modify the RNA in a specific way that activates it.

"One of the big questions in molecular biology is how genes are controlled,” explained senior author Dr. Judith Kimble, professor of biochemistry at the University of Wisconsin. "Our finding provides an important piece of the puzzle.”

Identification of this enzyme in C elegans should promote the search for similar enzymes in humans, possibly one day leading to new therapies. Said Dr. Kimble, "I think this is a big finding for anyone interested in how genes are regulated.”




Related Links:
University of Wisconsin

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hematology Consumables
Bioblood Devices
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.